Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CARRECA, Ignazio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.766
EU - Europa 1.888
AS - Asia 1.491
SA - Sud America 178
AF - Africa 27
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.729
SG - Singapore 523
CN - Cina 426
RU - Federazione Russa 399
IT - Italia 317
DE - Germania 290
UA - Ucraina 229
HK - Hong Kong 147
BR - Brasile 146
FI - Finlandia 134
PL - Polonia 124
VN - Vietnam 117
FR - Francia 88
GB - Regno Unito 85
IE - Irlanda 74
JP - Giappone 69
KR - Corea 53
SE - Svezia 50
IN - India 38
RO - Romania 23
NL - Olanda 19
MX - Messico 17
CA - Canada 15
IQ - Iraq 15
TR - Turchia 15
BE - Belgio 14
BD - Bangladesh 10
TH - Thailandia 10
AT - Austria 9
ES - Italia 9
AR - Argentina 8
VE - Venezuela 8
SA - Arabia Saudita 7
ZA - Sudafrica 7
CH - Svizzera 6
PH - Filippine 6
UZ - Uzbekistan 6
AM - Armenia 5
JO - Giordania 5
MY - Malesia 5
PK - Pakistan 5
UY - Uruguay 5
GR - Grecia 4
ID - Indonesia 4
IR - Iran 4
TN - Tunisia 4
TW - Taiwan 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
CL - Cile 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
LU - Lussemburgo 3
MA - Marocco 3
AU - Australia 2
CO - Colombia 2
EG - Egitto 2
GH - Ghana 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
OM - Oman 2
PS - Palestinian Territory 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.355
Salva come PNG Salva come JPEG
Città #
Ashburn 366
Singapore 327
Fairfield 252
Chandler 168
San Jose 166
Woodbridge 154
Hong Kong 145
Wilmington 132
Ann Arbor 117
Jacksonville 116
Houston 111
Seattle 99
Cambridge 81
Zgierz 80
Dublin 74
Frankfurt am Main 71
Moscow 68
Tokyo 66
Medford 62
Des Moines 57
Santa Clara 56
Hefei 55
Beijing 51
Nanjing 50
Palermo 46
Ho Chi Minh City 43
Kraków 40
Princeton 39
Altamura 37
Council Bluffs 37
Boardman 34
Tulsa 34
Lauterbourg 31
Los Angeles 26
Dearborn 25
Buffalo 24
Ludwigshafen am Rhein 22
Munich 22
Hanoi 21
Lawrence 21
Chicago 20
Kitzingen 20
New York 20
Seoul 20
Dallas 18
Nanchang 17
San Diego 17
São Paulo 17
Milan 16
Shenyang 16
Orem 15
Changsha 14
Saint Petersburg 13
Verona 13
Brussels 12
Seongnam 12
Tianjin 12
Helsinki 11
Nuremberg 11
Guangzhou 10
London 10
Da Nang 9
Hebei 9
Rome 9
Columbus 8
Denver 8
Belo Horizonte 7
Jiaxing 7
Naples 7
San Francisco 7
Turku 7
Brooklyn 6
Istanbul 6
San Mateo 6
The Dalles 6
Amsterdam 5
Auburn Hills 5
Baghdad 5
Cardiff 5
Kunming 5
Montevideo 5
Montreal 5
Rio de Janeiro 5
Taizhou 5
Yerevan 5
Amman 4
Chennai 4
City of London 4
Düsseldorf 4
Haiphong 4
Johannesburg 4
Ningbo 4
Nürnberg 4
Riyadh 4
Shanghai 4
Stockholm 4
Abidjan 3
Acquedolci 3
Baku 3
Biên Hòa 3
Totale 3.948
Salva come PNG Salva come JPEG
Nome #
Founder mutations in BRCA1 and BRCA2 genes 296
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 282
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo 267
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 262
Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy 260
Tailored vinorelbine-capecitabine treatment in elderly metastatic breast cancer patients. A SICOG phase II study 223
Randomized Multicenter Phase II Trial of Two Different Schedules of Irinotecan Combined with Capecitabine as First-Line Treatment in Metastatic Colorectal Carcinoma 218
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. 196
Cancer in the older person 194
Cancer chemotherapy in the older cancer patient 185
Combined treatment with fulvestrant plus capecitabine in elderly advanced breast cancer (EABC): Three-year evaluation of efficacy and safety 182
Reticulocytes can represent an early indicator of erythropoietic response to Darbepoetin alfa in the anemia by chemotherapy 181
Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG) 171
Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis. 170
1. Uncommon Unresectable Advanced Ulcerative Scirrhous Carcinoma of the Nipple Destroying skin, Chest, Muscles and Ribs. Complete Remission (CR) After Epidoxorubicin (EDOX) + Gemcitabine (GEM) Weekly Administration - A Case Report 167
EMATOPOIESI E INVECCHIAMENTO 166
Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O). 161
Weekly Dose-Dense Cisplatin-Epirubicin-Paclitaxel Administration with Granulocyte Colony-Stimulating Factor Support Does Not Substantially Improve Prognosis in Extensive Disease Small-Cell Lung Cancer A SICOG Phase II Study 155
An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer 152
Weekly cisplatin-epirubicin-paclitaxel vs. dose-dense cisplatin-epirubicin-vinorelbine in locally advanced breast cancer: Interim analysis of the SICOG 0302 phase III trial. 151
Capecitabine (XEL) + Oxaliplatin (OX) in elderly people (EP) with Colorectal Cancer (CRC): Comparison of safety (S) and feasibility (F) of two different schedules. Preliminary findings 144
Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect? 142
Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring 138
FULVESTRANT AND CAPECITABINE IN ELDERLY ADVANCED BREAST CANCER PATIENTS: THE PROPOSAL FOR AN EFFECTIVE AND SAFE COMBINED TREATMENT SCHEDULE. 136
Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5-fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC) 134
Antiangiogenic effects, safety and feasibility of two different capecitabine/Oxaliplatin-based schedules in elderly colorectal cancer patients 129
Myelotoxicity from cytostatic treatment, an important risk factor in the management of neoplasias in the elderly 127
Oncogeriatry: Communication, sharing, coordination of an emerging reality. The IIIrd Official Meeting of the AIOM Working Group on Oncogeriatry 127
Metronomic therapy irinotecan (IRI) capecitabine (CAP) plus bevacizumab (BEV) in treatment of advanced colorectal cancer (ACRC) in very elderly people. 126
Capecitabine (XEL) and oxaliplatin (OX) in combination with bevacizumab (BEV) in the management of elderly patients with advanced colorectal cancer (ACRC): Preliminary outcomes on safety and efficacy. 126
Sex and Gender in Ageing and Longevity: Highlights from an International Course 121
Antiangiogenic scheduling of lower dose chemotherapy in elderly patients with advanced colorectal cancer 120
VEGF and Chromogranin A (CgA): Possible new predictive factors in management of advanced prostatic cancer (APC) in elderly patients 119
VEGF values as a predictive factor of treatment efficiency in elderly women with advanced breast cancer 115
Sorafenib (SFB) low dose in octogenarians with advanced or inoperable (a/i) HCC: Toxicity and efficacy evaluation. 110
Safety and efficacy of two different schedules of capecitabine combined with oxaliplatin in the treatment of colon cancer in the elderly 103
SAFETY AND EFFICACY OF INHALED IL-2 THERAPY IN PRE-TREATED BREAST CANCER ELDERLY PATIENTS WITH PULMONARY METASTASES. 98
Non-Pegylated Liposomal Doxorubicin/Cyclophosphamide-based schedule As Antiangiogenic Treatment In Elderly Women With Advanced Breast Cancer 97
VEGF levels could affect outcomes in elderly breast cancer women 93
Sorafenib (SFB) treated elderly patients (E) with hepatocellular carcinoma (HCC): Chromogranine A (CGA) plus vascular endothelial growth factor (VEGF) as predicting factors (PF) of treatment outcome. 84
Totale 6.428
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 0 0 70
2021/2022376 20 95 7 9 9 17 14 17 47 51 22 68
2022/2023531 71 93 0 38 86 79 45 37 51 1 24 6
2023/2024256 13 39 9 10 17 27 26 54 10 6 10 35
2024/2025626 6 34 37 75 14 25 60 52 37 60 66 160
2025/20262.334 184 78 146 151 159 328 284 239 178 510 71 6
Totale 6.428